Hospital readmissions (heart failure‐ or adverse event‐related) · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Cardiac mortality · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Time to heart decompensation · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Disease‐free period at 30, 60 and 90 days · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Overall survival · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Quality of life · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Adverse events · heart failure in patients with Chagas cardiomyopathy
It is very uncertain whether carvedilol changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Cardiac mortality · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Incidence of pain with lidocaine pretreatment Pain scales · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Lidocaine may leads to lower pain ‐ lidocaine compared with placebo (low certainty).
1 finding from 1 review
Pain ‐ fentanyl · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Fentanyl may leads to lower pain ‐ fentanyl compared with placebo (low certainty).
1 finding from 1 review
Pain ‐ remifentanil · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Remifentanil may leads to lower pain ‐ remifentanil compared with placebo (low certainty).
1 finding from 1 review
Indirect measure of spasticity Modified Ashworth Scale · people with spasticity following stroke
It is very uncertain whether systemic antispasticity drugs changes indirect measure of spasticity Modified Ashworth Scale compared with placebo (very low certainty).
1 finding from 1 review
Adverse events Adverse events per participant · people with spasticity following stroke
It is very uncertain whether systemic antispasticity drugs changes adverse events Adverse events per participant compared with placebo (very low certainty).
1 finding from 1 review
Short‐term remission · adults with panic disorder
It is very uncertain whether all psychological therapies changes short‐term remission compared with SSRI (very low certainty).
1 finding from 1 review
Short‐term improvement Scale used (range; lower is better): Clinical Global Impression (1 to 7) Agoraphobic Cognitions Questionnaire (1 to 70) Panic Disorder Severity Scale (0 to 28) Brief Scale for Anxiety (0 to 60) · adults with panic disorder
1 finding from 1 review
Short‐term remission · adults with panic disorder
It is very uncertain whether all psychological therapies changes short‐term remission compared with other antidepressants (very low certainty).
1 finding from 1 review
Short‐term response · adults with panic disorder
All psychological therapies showed no clear difference in short‐term response compared with other antidepressants (low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
All psychological therapies showed no clear difference in dropouts for any reason compared with other antidepressants (low certainty).
1 finding from 1 review
Long‐term remission/response · adults with panic disorder
1 finding from 1 review